Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Bariatric surgery980 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03949 | 33810079 | Biomolecules | Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview. | 2021 | Details |
| A03951 | 33809676 | J Clin Med | Caspase-Cleaved Keratin 18 Measurements Identified Ongoing Liver Injury after Bariatric Surgery. | 2021 | Details |
| A03976 | 33804302 | J Clin Med | The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients. | 2021 | Details |
| A04075 | 33769376 | Curr Opin Gastroenterol | The role of bariatric surgery in the management of nonalcoholic steatohepatitis. | 2021 | Details |
| A04138 | 33744305 | Gastroenterology | Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity. | 2021 | Details |
| A04257 | 33686111 | Sci Rep | A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery. | 2021 | Details |
| A04280 | 33679051 | J Clin Exp Hepatol | Successful Outcome of Bariatric Surgery in Living Donor Liver Transplant Recipients With Multidisciplinary Approach: A Preliminary Experience. | 2020 | Details |
| A04288 | 33676874 | Surg Obes Relat Dis | The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis. | 2020 | Details |
| A04321 | 33665755 | Obes Surg | Decision Tree for the Performance of Intraoperative Liver Biopsy During Bariatric Surgery. | 2021 | Details |
| A04357 | 33648885 | Obes Res Clin Pract | Comparison between non-invasive methods and liver histology to stratify liver fibrosis in obese patients submitted to bariatric surgery. | 2021 | Details |
| A04399 | 33633080 | J Pediatr Gastroenterol Nutr | Clinical and Esophagogastroduodenoscopy Findings in Pediatric Patients With Severe Obesity Evaluated Before Bariatric Surgery. | 2021 | Details |
| A04436 | 33616848 | Obes Surg | Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04445 | 33614318 | Cureus | Treatment of Fatty Liver Disease: The Present and the Future. | 2021 | Details |
| A04473 | 33603714 | Front Endocrinol (Lausanne) | Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery. | 2021 | Details |
| A04501 | 33595790 | Obes Surg | Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review. | 2021 | Details |
| A04625 | 33559024 | Biol Trace Elem Res | Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity. | 2021 | Details |
| A04668 | 33546191 | Biomedicines | Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. | 2021 | Details |
| A04716 | 33530440 | J Clin Med | NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations. | 2021 | Details |
| A04773 | 33511092 | Front Pediatr | Childhood and Adolescent Obesity: A Review. | 2021 | Details |
| A04879 | 33470379 | Arq Bras Cir Dig | BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE? | 2021 | Details |
| A04880 | 33469809 | Dig Dis Sci | Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis. | 2021 | Details |
| A04894 | 33464677 | Diabetes Obes Metab | Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. | 2021 | Details |
| A04977 | 33429859 | Nutrients | Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity. | 2021 | Details |
| A05119 | 33368954 | Diabetes Obes Metab | Pioglitazone and bariatric surgery are the most effective treatments for non-alcoholic steatohepatitis: A hierarchical network meta-analysis. | 2021 | Details |
| A05285 | 33312425 | World J Hepatol | Phase angle and non-alcoholic fatty liver disease before and after bariatric surgery. | 2020 | Details |
| A05299 | 33309037 | Am J Surg | The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests. | 2020 | Details |
| A05310 | 33306598 | J Chin Med Assoc | Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis. | 2021 | Details |
| A05345 | 33293347 | Diabetes Care | Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05429 | 33260239 | Horm Metab Res | The Role of Brown Adipose Tissue in the Development and Treatment of Nonalcoholic Steatohepatitis: An Exploratory Gene Expression Study in Mice. | 2020 | Details |
| A05431 | 33259835 | Metabolism | The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A05463 | 33248441 | J Clin Endocrinol Metab | Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery. | 2021 | Details |
| A05497 | 33232525 | J Gastroenterol Hepatol | FibroScan-aspartate aminotransferase score in an Asian cohort of non-alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery. | 2020 | Details |
| A05506 | 33225408 | Obes Surg | Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis. | 2020 | Details |
| A05523 | 33219609 | Liver Int | Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids. | 2020 | Details |
| A05524 | 33219119 | BMJ Open Diabetes Res Care | Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans. | 2020 | Details |
| A05583 | 33200011 | World J Hepatol | Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! | 2020 | Details |
| A05610 | 33190175 | Obes Surg | Development and Validation of a Predictive Model of Success in Bariatric Surgery. | 2020 | Details |
| A05637 | 33179890 | Am Fam Physician | Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management. | 2020 | Details |
| A05677 | 33163832 | Hepatol Commun | Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis. | 2020 | Details |
| A05681 | 33161161 | Clin Gastroenterol Hepatol | Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study. | 2020 | Details |
| A05690 | 33156104 | Am J Gastroenterol | Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment. | 2020 | Details |
| A05692 | 33153965 | Surg Obes Relat Dis | Use of noninvasive scores for advanced liver fibrosis can guide the need for hepatic biopsy during bariatric procedures. | 2020 | Details |
| A05796 | 33114543 | J Clin Med | Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity. | 2020 | Details |
| A05900 | 33081272 | Life (Basel) | Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD. | 2020 | Details |
| A05904 | 33080603 | Digestion | Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH. | 2020 | Details |
| A05953 | 33064150 | J Clin Endocrinol Metab | The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients. | 2021 | Details |
| A05982 | 33052552 | Obes Surg | Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan. | 2020 | Details |
| A06022 | 33036939 | Surg Obes Relat Dis | Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery. | 2020 | Details |
| A06023 | 33036418 | Diagnostics (Basel) | Optimization of Point-Shear Wave Elastography by Skin-to-Liver Distance to Assess Liver Fibrosis in Patients Undergoing Bariatric Surgery. | 2020 | Details |
| A06107 | 33005474 | Liver Res | MiR-22 as a metabolic silencer and liver tumor suppressor. | 2020 | Details |
| A06110 | 33004251 | Rev Gastroenterol Mex (Engl Ed) | Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. | 2020 | Details |
| A06114 | 33001570 | Diabetes Obes Metab | Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice. | 2020 | Details |
| A06147 | 32987188 | Mol Metab | Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease. | 2020 | Details |
| A06164 | 32981386 | Expert Rev Clin Pharmacol | The pharmacological treatment of nonalcoholic fatty liver disease in children. | 2020 | Details |
| A06167 | 32981002 | Obes Surg | The Use of Transient Elastography Technology in the Bariatric Patient: a Review of the Literature. | 2020 | Details |
| A06172 | 32979184 | Obes Surg | Prevalence and Factors Associated with Hepatic Iron Overload in Obese Individuals Undergoing Bariatric Surgery: a Cross-Sectional Study. | 2020 | Details |
| A06236 | 32959331 | Obes Surg | Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study. | 2020 | Details |
| A06245 | 32952877 | World J Hepatol | Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis. | 2020 | Details |
| A06278 | 32943763 | Int J Obes (Lond) | Modifications of IGF2 and EGFR plasma protein concentrations in NAFLD patients after bariatric surgery. | 2020 | Details |
| A06284 | 32942044 | Cell Mol Gastroenterol Hepatol | Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner. | 2020 | Details |
| A06323 | 32929103 | Sci Rep | Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study. | 2020 | Details |
| A06373 | 32909011 | medRxiv | Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19. | 2020 | Details |
| A06389 | 32898995 | Medicine (Baltimore) | Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease. | 2020 | Details |
| A06421 | 32885600 | Clin Obes | Bariatric surgery during the evolution of fatty liver-A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography. | 2020 | Details |
| A06439 | 32881244 | Liver Int | A tool to predict progression of non-alcoholic fatty liver disease in severely obese patients. | 2021 | Details |
| A06498 | 32852705 | J Endocrinol Invest | Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease. | 2020 | Details |
| A06537 | 32833053 | Langenbecks Arch Surg | Mechanisms of nonalcoholic fatty liver disease and implications for surgery. | 2020 | Details |
| A06543 | 32832402 | J Clin Transl Hepatol | NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. | 2020 | Details |
| A06594 | 32814993 | Curr Gastroenterol Rep | Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06667 | 32788075 | Surg Obes Relat Dis | Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy. | 2020 | Details |
| A06695 | 32777481 | Biochim Biophys Acta Mol Cell Biol Lipids | Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis. | 2020 | Details |
| A06706 | 32774765 | World J Gastrointest Surg | Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study. | 2020 | Details |
| A06715 | 32772323 | J Endocrinol Invest | Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men. | 2020 | Details |
| A06757 | 32758151 | BMC Gastroenterol | Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems. | 2020 | Details |
| A06857 | 32720262 | Obes Surg | Bariatric Surgery in the Setting of Liver Cirrhosis with Portal Hypertension: the Confection and Particularities of Roux-en-Y Gastric Bypass in a High-Risk Patient. | 2020 | Details |
| A06880 | 32712045 | Asian J Surg | Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice. | 2020 | Details |
| A06945 | 32690320 | Obes Res Clin Pract | Influence of LGALS3 and PNPLA3 genes in non-alcoholic steatohepatitis (NASH) in patients undergone bariatric surgery. | 2020 | Details |
| A07028 | 32652799 | Liver Int | High-protein diet more effectively reduces hepatic fat than low-protein diet despite lower autophagy and FGF21 levels. | 2020 | Details |
| A07053 | 32640105 | J Intern Med | A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study. | 2020 | Details |
| A07055 | 32638913 | Rev Col Bras Cir | Comparison of the severity of non-alcoholic fatty liver disease in diabetic and non-diabetic obese patients. | 2020 | Details |
| A07085 | 32628898 | United European Gastroenterol J | Metabolic endoscopy: Today's science-tomorrow's treatment. | 2020 | Details |
| A07111 | 32619031 | Diabet Med | Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
| A07165 | 32595023 | Obes Res Clin Pract | Pro-inflammatory HDL in women with obesity and nonalcoholic steatohepatitis. | 2020 | Details |
| A07292 | 32553765 | Gastroenterology | Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis. | 2020 | Details |
| A07309 | 32545403 | Int J Mol Sci | Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07350 | 32529354 | Obes Surg | Correlation between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease before and after Metabolic Bariatric Surgery. | 2020 | Details |
| A07398 | 32514465 | JGH Open | No association between binge eating disorder and severity of non-alcoholic fatty liver disease in severely obese patients. | 2020 | Details |
| A07504 | 32469428 | Diabetes Metab Res Rev | Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease. | 2020 | Details |
| A07506 | 32467498 | Am J Ther | How to Reduce Cardiovascular Risk in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07535 | 32451920 | Obes Surg | Elastic Fibers Density: a New Parameter of Improvement of NAFLD in Bariatric Surgery Patients. | 2020 | Details |
| A07555 | 32444690 | Sci Rep | Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study. | 2020 | Details |
| A07557 | 32444241 | Clin Nutr | Medium term post-bariatric surgery deficit of vitamin B12 is predicted by deficit at time of surgery. | 2020 | Details |
| A07564 | 32442908 | Cytokine | Gastric banding-associated weight loss diminishes hepatic Tsukushi expression. | 2020 | Details |
| A07592 | 32431529 | Diabetes Metab Syndr Obes | Changes in Serum Nesfatin-1 After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07595 | 32431115 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. | 2020 | Details |
| A07614 | 32420347 | Biomed Res Int | The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods. | 2020 | Details |
| A07772 | 32359748 | Clin Nutr ESPEN | Diagnostic of hepatic fibrosis with the XL probe of the Fibroscan versus biopsies in patients candidates to bariatric surgery. | 2020 | Details |
| A07804 | 32351187 | Curr Diabetes Rev | Inter-Tissue and Intra-Tissue Co-Expression Networks in Human Metabolism: Morphological Evaluation of the Link Between Transcription Factors ERβ and NFAT in Morbid Obesity. | 2021 | Details |
| A07846 | 32336663 | Surg Obes Relat Dis | Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review. | 2020 | Details |
| A07868 | 32329579 | Liver Int | Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy. | 2020 | Details |